KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS).
Our technology can revolutionize HA delivery for medical and surgical needs, in the field of:
Aesthetic
Rheumatology
Reconstructive surgery
Drug delivery system
Veterinary
Company Details
- Employees
- 3
- Founded
- -
- Address
- Route De La Galaise 34, C/o Fongit,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- kylys.com
- Keywords
- Belladama Aesthetic.
- HQ
- Plan-les-Ouates, Geneva
Kylys Questions
Kylys's website is kylys.com
Kylys's LinkedIn profile is https://ch.linkedin.com/company/kylys
Kylys has
3 employees.
View email and phone details for 3
employees at Kylys.
Kylys's industry is
Pharmaceutical Manufacturing
Kylys's top competitors are
Abcello Sàrl,
Kylys Aesthetics Sa,
Louna Aesthetics,
Olbios Sàrl,
Belladama Aesthetic,
Frilab Sa,
Grupo Kyly,
Ebamed,
Frelab,
Fongit.
Kylys's categories are Pharmaceutical Manufacturing
Kylys's founding year is 2017
